Title for MeetingAbstracts
Alphabetical listing of titles
Meta-analysis of the CD4 cell response to 3 doses of subcutaneous interleukin-2 (scIL-2) across 3 Vanguard studies.
Meta-analysis of the concordance between anti-retroviral effects on HIV-1 RNA and CD4 count and progression to AIDS or death.
Meta-analysis of the effectiveness of air fluidized therapy for the treatment of decubitus ulcers with geriatric populations.
Meta-analysis of the effects of managed care on obstetrical outcomes.
Meta-analysis of thrombolytic therapy in the treatment of acute stroke. Do we have the answers?.
Meta-analysis of two trials of ZDV/ddI vs ZDV/ddI/NVP.
Meta-Analysis of Uncontrolled Studies.
Meta-analysis shows significant benefit with bone material and bone substitutes as compared to open flap debridement alone for the treatment of periodontal defects.
Meta-analysis, para-analysis or paralysis: the ethics and difficulties of gathering evidence based data for decision-making by individual patients.
Meta-analysis: what role does 'grey literature' play?.
Meta-ethnography and health technology assessment: towards a systematic integration of patient's perspectives.
Meta-regression for complex questions that are not directly addressed in the available literature.
Meta-regression or meta-analysis? Contrasting results when applied to trials of aprotinin to minimise operative blood loss.
Meta-survey of plant and herb material as a treatment for HIV.
Metaanalytical findings with psychosocial interventions.
Metabolic abnormalities and cardiovascular risk factors in HIV-infected hispanics in western MA.
Metabolic abnormalities and HAART in a cohort of HIV infected drug abusers.
Metabolic abnormalities and lipodystrophy in AIDS patients treated with protease inhibitors in a Brazilian HIV reference center.
Metabolic alterations in patients with HIV illness.
Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy (HAART): improvement in serum triglyceride and cholesterol levels.
Metabolic and bioenergetic adaptations in skeletal muscle to real or simulated weightlessness.
Metabolic and body composition abnormalities in HIV-infected patients treated with HAART.
Metabolic and body composition changes in HIV-infected children on antiretroviral therapy.
Metabolic and body composition changes in patients switching from a protease inhibitor-containing regimen to Abacavir (ABC), Efavirenz (EFV) or Nevirapine (NVP). Twelve-month results of a randomized study (LIPNEFA).
Metabolic and body shape changes in a ART naive-cohort initiating generic HAART in South India.
Metabolic and clinical evaluation of lipodystrophy syndrome (LD) in HIV-1-infected adults receiving initial HAART with or without a protease inhibitor (PI): 48-week data from the CNAF3007 study.
Metabolic and Immunologic Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis.
Metabolic and morphologic effects of benfluorex in 25 HIV-infected patients with lipodystrophy.
Metabolic and morphologic tolerability of nevirapine in naive or pre-treated HIV 1 infected patients.
Metabolic and renal profile before and after tenofovir DF.